A New Drug Discovery Platform: Application to DNA Polymerase Eta and Apurinic/Apyrimidinic Endonuclease 1.

APE1 DNA damage response POLH Pol eta X-ray crystallography cancer therapeutics fragment-based drug discovery polymerases structure-based drug discovery synthetic lethality targeted protein degradation

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Nov 2023
Historique:
received: 29 08 2023
revised: 26 10 2023
accepted: 27 10 2023
medline: 9 12 2023
pubmed: 9 12 2023
entrez: 9 12 2023
Statut: epublish

Résumé

The ability to quickly discover reliable hits from screening and rapidly convert them into lead compounds, which can be verified in functional assays, is central to drug discovery. The expedited validation of novel targets and the identification of modulators to advance to preclinical studies can significantly increase drug development success. Our SaXPy

Identifiants

pubmed: 38068959
pii: ijms242316637
doi: 10.3390/ijms242316637
pmc: PMC10706420
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCATS NIH HHS
ID : R43 TR001736
Pays : United States
Organisme : NIGMS NIH HHS
ID : R44 GM132796
Pays : United States
Organisme : NCI NIH HHS
ID : R43 CA254552
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008280
Pays : United States
Organisme : NIH HHS
ID : ES029518, CA148629, ES014811, ES028949, CA238061, CA236911, AG069740 and ES032522
Pays : United States

Références

J Med Chem. 2012 Apr 12;55(7):3101-12
pubmed: 22455312
Nat Rev Cancer. 2008 Mar;8(3):193-204
pubmed: 18256616
Science. 2007 Nov 9;318(5852):967-70
pubmed: 17991862
Mutat Res Genet Toxicol Environ Mutagen. 2015 Nov;793:19-29
pubmed: 26520369
Methods Mol Biol. 2013;1008:357-88
pubmed: 23729259
J Med Chem. 2009 Jan 8;52(1):20-32
pubmed: 19072053
Mol Cell. 2005 Feb 4;17(3):463-70
pubmed: 15694346
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):4411-6
pubmed: 25831546
Mol Cancer Ther. 2004 Jun;3(6):679-86
pubmed: 15210853
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Prog Nucl Magn Reson Spectrosc. 2016 Nov;97:82-125
pubmed: 27888841
J Neurosurg. 2017 Feb;126(2):446-459
pubmed: 27177180
PLoS One. 2023 Jan 18;18(1):e0280526
pubmed: 36652434
Nat Med. 2013 Feb;19(2):202-8
pubmed: 23291630
Oncogene. 2022 Aug;41(32):3969-3977
pubmed: 35768547
Annu Rev Biochem. 2018 Jun 20;87:239-261
pubmed: 29494238
ACS Chem Biol. 2013 Aug 16;8(8):1722-9
pubmed: 23679919
Nature. 2000 Jan 27;403(6768):451-6
pubmed: 10667800
J Biol Chem. 2001 Dec 28;276(52):49283-8
pubmed: 11677235
Int J Cancer. 2012 Nov 15;131(10):2433-44
pubmed: 22377908
J Cell Physiol. 2021 Jun;236(6):4106-4120
pubmed: 33184862
Mol Cancer Ther. 2017 Jun;16(6):1010-1020
pubmed: 28341788
J Biol Chem. 2013 Mar 22;288(12):8445-8455
pubmed: 23355472
J Transl Med. 2010 Nov 27;8:126
pubmed: 21110884
Antioxid Redox Signal. 2014 Feb 1;20(4):678-707
pubmed: 23834463
Nature. 2005 Apr 14;434(7035):917-21
pubmed: 15829967
Genes Dev. 2020 Mar 1;34(5-6):360-394
pubmed: 32029455
Biochemistry. 1972 Sep 12;11(19):3610-8
pubmed: 4626532
Protein Sci. 2020 Jan;29(1):52-65
pubmed: 31531901
Biochemistry. 2014 May 6;53(17):2793-803
pubmed: 24716551
Clin Cancer Res. 2001 Nov;7(11):3510-8
pubmed: 11705870
Mutagenesis. 2020 Feb 13;35(1):27-38
pubmed: 31816044
Trends Mol Med. 2005 Nov;11(11):503-11
pubmed: 16214418
Drug Discov Today. 2020 Mar;25(3):485-490
pubmed: 31877353
Curr Protein Pept Sci. 2022;23(2):77-88
pubmed: 35388752
Front Oncol. 2021 Nov 19;11:778925
pubmed: 34900730
J Synchrotron Radiat. 2002 Nov 1;9(Pt 6):401-6
pubmed: 12409628
Drug Discov Today. 2021 Jan;26(1):218-228
pubmed: 33148489
Bioorg Med Chem Lett. 2019 Dec 1;29(23):126717
pubmed: 31635932
Mutat Res. 2001 May 10;485(4):283-307
pubmed: 11585362
Genes (Basel). 2023 Jan 09;14(1):
pubmed: 36672916
Appl Environ Microbiol. 2018 Dec 13;85(1):
pubmed: 30366994
J Med Chem. 2020 Apr 23;63(8):4315-4333
pubmed: 32223236
Methods Enzymol. 2017;592:283-327
pubmed: 28668125
Cancer Res. 2018 Dec 1;78(23):6549-6560
pubmed: 30297532
Nature. 2005 Apr 14;434(7035):913-7
pubmed: 15829966
ACS Med Chem Lett. 2010 Feb 04;1(1):44-8
pubmed: 24900174
Clin Cancer Res. 2005 Apr 1;11(7):2747-55
pubmed: 15814657
PLoS One. 2013 Dec 20;8(12):e83978
pubmed: 24376779
PLoS One. 2009 Jun 01;4(6):e5740
pubmed: 19484131
Cancer Res. 2002 Nov 1;62(21):6318-22
pubmed: 12414663
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Cancer Res. 2001 Nov 1;61(21):7727-30
pubmed: 11691784
PLoS One. 2012;7(10):e47974
pubmed: 23110144
Curr Res Pharmacol Drug Discov. 2021 Feb 05;2:100017
pubmed: 34909652
Sci Rep. 2018 Feb 9;8(1):2771
pubmed: 29426857
Science. 1996 Nov 29;274(5292):1531-4
pubmed: 8929414
Annu Rev Med. 2022 Jan 27;73:231-250
pubmed: 34644155
Essays Biochem. 2020 Oct 26;64(5):831-843
pubmed: 32648895
NAR Cancer. 2023 Feb 06;5(1):zcad006
pubmed: 36755963
Prog Biophys Mol Biol. 2021 Aug;163:130-142
pubmed: 33115610
Cancers (Basel). 2021 Feb 14;13(4):
pubmed: 33672884
Cancer Cell. 2021 Jan 11;39(1):38-53.e7
pubmed: 33217343
J Biol Chem. 2023 Mar;299(3):102991
pubmed: 36758800
Neuro Oncol. 2011 May;13(5):471-86
pubmed: 21377995
Nat Rev Drug Discov. 2012 Nov;11(11):873-86
pubmed: 23060265
PLoS One. 2021 Sep 16;16(9):e0257473
pubmed: 34529719
Front Oncol. 2012 Dec 05;2:186
pubmed: 23227453
J Cell Signal. 2021;2(3):151-161
pubmed: 34557865
Cancers (Basel). 2020 Oct 02;12(10):
pubmed: 33023096
Acta Pharmacol Sin. 2018 Aug;39(8):1359-1372
pubmed: 29849128
Mol Cell. 2019 Mar 7;73(5):885-899.e6
pubmed: 30686591
PLoS One. 2021 Jun 1;16(6):e0252587
pubmed: 34061890
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Mutat Res Genet Toxicol Environ Mutagen. 2022 Jun;878:503498
pubmed: 35649682
Mol Cancer Ther. 2003 Oct;2(10):1061-6
pubmed: 14578471
Mol Cell. 2015 Nov 19;60(4):547-60
pubmed: 26590714
Int J Mol Sci. 2020 Dec 31;22(1):
pubmed: 33396303
Nucleic Acids Res. 2005 Aug 19;33(15):4711-24
pubmed: 16113242
Cancer Res. 2004 Sep 15;64(18):6469-75
pubmed: 15374956
J Med Chem. 2020 May 14;63(9):4749-4761
pubmed: 32240584
N Engl J Med. 2015 Jul 30;373(5):428-37
pubmed: 26222558
Biochemistry. 2000 Apr 25;39(16):4575-80
pubmed: 10769112
Cancer Res. 2005 Nov 1;65(21):9799-806
pubmed: 16267001
Eur J Med Chem. 2023 Feb 15;248:115044
pubmed: 36621139
Cancer Res. 2019 Jul 15;79(14):3714-3724
pubmed: 31064846
Oncotarget. 2014 May 30;5(10):3273-86
pubmed: 24830350
Chromosoma. 2012 Feb;121(1):1-20
pubmed: 22048164
Mol Cell. 2023 May 4;83(9):1429-1445.e8
pubmed: 37044098
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10660-10665
pubmed: 30275308
Clin Cancer Res. 2017 Feb 1;23(3):697-706
pubmed: 27503200
Bioorg Med Chem. 2017 May 1;25(9):2531-2544
pubmed: 28161249
Biochemistry. 2018 Feb 20;57(7):1262-1273
pubmed: 29345908
DNA Repair (Amst). 2008 Feb 1;7(2):177-86
pubmed: 17974506
Nucleic Acids Res. 2021 Aug 20;49(14):8214-8231
pubmed: 34320214
Nucleic Acids Res. 1994 Nov 25;22(23):4884-9
pubmed: 7800476
Clin Cancer Res. 2005 Oct 15;11(20):7405-14
pubmed: 16243814
Biochemistry. 2014 Oct 21;53(41):6520-9
pubmed: 25251148
Sci Rep. 2022 Nov 2;12(1):18461
pubmed: 36323739
Cell Mol Life Sci. 2010 Nov;67(21):3621-31
pubmed: 20809131
Brain Pathol. 1999 Jul;9(3):469-79
pubmed: 10416987
DNA Repair (Amst). 2004 Jan 5;3(1):1-12
pubmed: 14697754
Clin Cancer Res. 2002 Sep;8(9):3008-18
pubmed: 12231548
ChemMedChem. 2012 Oct;7(10):1825-39
pubmed: 22952012
Mol Pharmacol. 2008 Mar;73(3):669-77
pubmed: 18042731
Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43
pubmed: 15824325
J Biol Chem. 2019 Dec 13;294(50):19048-19054
pubmed: 31685662

Auteurs

Debanu Das (D)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.
Accelero Biostructures, Inc., San Carlos, CA 94070, USA.

Matthew A J Duncton (MAJ)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.

Taxiarchis M Georgiadis (TM)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.

Patricia Pellicena (P)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.

Jennifer Clark (J)

Mitchell Cancer Institute and Department of Pharmacology, University of South Alabama, Mobile, AL 36604, USA.

Robert W Sobol (RW)

Mitchell Cancer Institute and Department of Pharmacology, University of South Alabama, Mobile, AL 36604, USA.
Department of Pathology & Laboratory Medicine, Warrant Alpert Medical School & Legorreta Cancer Center, Brown University, Providence, RI 02912, USA.

Millie M Georgiadis (MM)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

John King-Underwood (J)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.

David V Jobes (DV)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.
Mid-Atlantic BioTherapeutics, Inc., Doylestown, PA 18902, USA.

Caleb Chang (C)

Department of BioSciences, Rice University, Houston, TX 77251, USA.

Yang Gao (Y)

Department of BioSciences, Rice University, Houston, TX 77251, USA.

Ashley M Deacon (AM)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.
Accelero Biostructures, Inc., San Carlos, CA 94070, USA.

David M Wilson (DM)

XPose Therapeutics, Inc., San Carlos, CA 94070, USA.
Biomedical Research Institute, Hasselt University, 3500 Diepenbeek, Belgium.
Belgium & Boost Scientific, 3550 Heusden-Zolder, Belgium.

Classifications MeSH